These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1547980)

  • 41. Rh prevention: a report and analysis of a national programme.
    Eklund J; Nevanlinna HR
    J Med Genet; 1973 Mar; 10(1):1-7. PubMed ID: 4633302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Occurrence of hemolytic disease of the newborn caused by irregular antibodies].
    Mickley H
    Ugeskr Laeger; 1983 Jun; 145(23):1763-5. PubMed ID: 6410568
    [No Abstract]   [Full Text] [Related]  

  • 43. [Immunological aspects of the prevention of hemolytic disease of the newborn].
    Antonian AK
    Zh Eksp Klin Med; 1973; 13(6):44-9. PubMed ID: 4215267
    [No Abstract]   [Full Text] [Related]  

  • 44. [Prevention and treatment of Rh. isoimmunization. Results].
    Martínez M; Lozano G; Flores F; Fernández P; Garrido G
    Acta Obstet Ginecol Hisp Lusit; 1971 Mar; 19(2):149-57. PubMed ID: 4996734
    [No Abstract]   [Full Text] [Related]  

  • 45. [Prevention of isoimmunization Rh in Italy].
    Dambrosio F
    Pathologica; 1972; 64(929):119-34. PubMed ID: 4210236
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunohaematological aspects of modern prenatal, maternal and newborn care.
    Neubauer G; Joó-Szabados T; Kovács E; Székessy V; Wohlmuth G
    Ann Immunol Hung; 1972; 16(0):277-82. PubMed ID: 4213173
    [No Abstract]   [Full Text] [Related]  

  • 47. A review of the production and clinical use of intravenous Anti-D immunoglobulin.
    Walsh TJ; O'Riordan JP
    Ir Med J; 1982 Jul; 75(7):243-4. PubMed ID: 6813287
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of leukocytic isosensitization in pregnancy on the condition of the newborn infant].
    Kuznechikova VV; Vasil'eva ZF; Poliakova GP
    Vopr Okhr Materin Det; 1971 Jan; 16(1):40-5. PubMed ID: 4995798
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical and laboratory contribution to the prevention of fetal hemoblastosis].
    Carbonini M; Follini G
    Ann Ostet Ginecol Med Perinat; 1972 Aug; 93(8):579-84. PubMed ID: 4202141
    [No Abstract]   [Full Text] [Related]  

  • 50. [Prophylaxis of Rh isoimmunization].
    Policlinico Prat; 1968 Feb; 75(6):188-90. PubMed ID: 4191604
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention of Rh isoimmunization.
    Clarke CA
    Prog Med Genet; 1972; 8():169-223. PubMed ID: 4110995
    [No Abstract]   [Full Text] [Related]  

  • 52. [The effect of anti-rhesus (D)-immune prophylaxis in the Netherlands (1969-1976)].
    Splinter TA; Borst-Eilers E
    Ned Tijdschr Geneeskd; 1977 Dec; 121(51):2038-43. PubMed ID: 412112
    [No Abstract]   [Full Text] [Related]  

  • 53. Non-"D" rhesus and irregular antibodies--an approach to management.
    Dornan KJ
    Ir Med J; 1982 Mar; 75(3):79-82. PubMed ID: 6804410
    [No Abstract]   [Full Text] [Related]  

  • 54. [Prevention of Rh immunization by anti-D globulin injection after birth and abortion].
    Vardy J; Halbrecht I
    Harefuah; 1972 Aug; 83(3):115-20. PubMed ID: 4118291
    [No Abstract]   [Full Text] [Related]  

  • 55. Some epidemiological aspects of the prevention of Rh isoimmunization.
    Walker W
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):431-5. PubMed ID: 5003520
    [No Abstract]   [Full Text] [Related]  

  • 56. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 57. The mechanism of the action of anti-D in the prophylaxis of Rhesus sensitization.
    Hummel K
    Ann Immunol Hung; 1972; 16(0):160-73. PubMed ID: 4213456
    [No Abstract]   [Full Text] [Related]  

  • 58. [Results of anti-Rh-immunoprophylaxis in the Berlin-Friedrichshain hospital].
    Rössner P; Moeller HG; Krüger D
    Zentralbl Gynakol; 1976; 98(16):1005-16. PubMed ID: 823738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An analysis of the efficiency of a Rhesus haemolytic disease prophylaxis programme.
    Crowle PM
    Br J Prev Soc Med; 1974 May; 28(2):101-3. PubMed ID: 4211794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
    Zavala C; Salamanca F
    Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.